glp-1 light headed drugs tied to elevated risk of low blood pressure episodes Glucagon-like peptide 1 in health

Mol Cell Biochem (2021) 476(6):2491501

It is being studied for androgenetic alopecia, telogen effluvium, and other forms of hair thinning, with a focus on increasing hair follicle size and density

Since retatrutide heart rate effects are mediated through the glucagon receptor cAMP-PKA pathway rather than the sympathetic system, beta blockers may not fully counteract retatrutide-induced increases

It is therefore tempting to add GLP-1R agonists to the small list of glucose-lowering agents that exert anti-inflammatory actions independent of changes in glucoregulation

Additional Wegovy-specific risks that require monitoring include pancreatitis (presenting as severe abdominal pain), cholelithiasis (gallstones), and potential worsening of diabetic retinopathy in patients with diabetes